insights_auto
Why is GANX down 4.82%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$1.00
arrow_downward
-4.82%(-0.051) 1D
$1.00
arrow_upward
+0.06% (+0.00060)bedtimeAfter hours
Closed: Nov 20, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.02
High
$1.10
Low
$0.97
Mkt. cap
44.50M
Avg. vol.
690.72K
Volume
586.26K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.02
High
$1.10
Low
$0.97
Mkt. cap
44.50M
Avg. vol.
690.72K
Volume
586.26K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
FOREX.com
·
2 hours ago
S&P 500, Nasdaq 100 Drive into Correction Territory
TradingView
·
4 hours ago
Ed Yardeni Says Investors Are Overreacting to S&P 500 Selloff
TradingKey
·
7 hours ago
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
cwibc.co.id
·
1 hour ago
Wall Street Sell-Off Pushes S&P 500 and Dow Into Correction
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com